Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05488847
PHASE4

Opioid-Free Pain Protocol After Shoulder Arthroplasty

Sponsor: Henry Ford Health System

View on ClinicalTrials.gov

Summary

This randomized, single blinded, clinical trial aims to investigate the efficacy of a multimodal pain control regimen for shoulder arthroplasty. Patients who receive a multimodal pain control regimen alone (study group) will be compared to patients who receive a multimodal pain control regimen plus a standard prescription of an opioid containing medication (comparison group). The primary outcome is average daily Numerical Rating Scale (NRS) pain score in the first 10 days after surgery. We hypothesize that there will be no significant difference in the primary outcome between the two groups.

Official title: Multimodal Nonopioid Pain Protocol Following Shoulder Arthroplasty Surgery

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

83

Start Date

2022-06-25

Completion Date

2026-09-01

Last Updated

2026-02-10

Healthy Volunteers

Yes

Interventions

DRUG

Celecoxib

preoperative pain medication given to all patients

DRUG

Pregabalin

preoperative and discharge pain medication given to all patients

DRUG

Tramadol

preoperative pain medication given to all patients

DRUG

Dexamethasone

Intraoperative and discharge pain medication given to all patients

DRUG

Acetaminophen

Intraoperative and discharge pain medication given to all patients

DRUG

Ropivicaine

Intraoperative pain medication given to all patients

DRUG

Epinephrine

Intraoperative pain medication given to all patients

DRUG

Ketorolac

Intraoperative pain medication given to all patients

DRUG

Tizanidine

Discharge pain medication given to all patients

DRUG

Magnesium

Discharge pain medication given to all patients

DRUG

Ibuprofen

Discharge pain medication given to all patients

DRUG

Oxycodone Hydrochloride 5 Mg

Only given to active comparator group

Locations (1)

Henry Ford Health

Detroit, Michigan, United States